Abstract:Aim: To observe the proliferation and differentiation of bone marrow-derived mesenchymal stem cells (MSCs), and analyze the cytothesis and reconstruction ability of ischemic myocardial cells as well as its influence on heart function of after injecting MSCs (following the mononuclear cell, in vitro culture, purification and induction) into post-infarct the myocardium. Methods: The experiment was conducted in Anhui Provincial Stem Cells Research and Treatment Center from July 2005 to April 2006. Forty healthy male clean New Zealand rabbits were randomly divided into four groups: MSCs group, 5-aza-treated bone marrow-derived mesenchymal stem cells (5-aza-treated MSCs group), fresh bone marrow mononuclear cells (BMMNCs group) and control group, 10 in each group. Rabbits in each group were ligated of the left anterior descending coronary artery (LAD) below the left auricular appendage to establish the myocardial infarction models. The successful myocardial infarct models were recognized by arc-like elevation of S-T segments in Electrocardiogram (EKG). Two weeks later, 1×106 the third generation of MSCs were injected into MSCs group, 1×106 the third generation of MSCs after inducing 5-aza for 24 hours were injected into the 5-aza-treated MSCs group. 2.5×107/400 μL mononuclear cells were injected into the BMMNCs; group. 400 μL-DMEM medium was injected into the control group. Cardiac function was evaluated by ultrasound cardiotachograph at weeks 2 and 4 before operation, before and after transplantation, respectively. The blood perfusion in ischemic myocardium of the rabbits was observed by myocardial acoustic contrast. Cell growth in infarcted region was measured by immunofluorescence test at week 8 after cell transplantation. The capillary densities were counted under ordinary microscope by hemotoxylin-eosin staining (HE staining). Results: Nine rabbits in MSCs group, nine in 5-aza-treated MSCs group, ten in BMMNCs group and six in control group were involved in the analysis of the results (other rabbits died for modeling). (1) Detection of heart function by Echocardiography: The left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS) were fundamentally the same in each group before modeling, before tansplantation. As compared with the control group, the or, LVEF and LVFS were significantly increased in the MSCs group and 5-aza-treated MSCs group [control group: (60.4± 5.1)%, (62.4±7.8)%; (28.8±1.4)%, (27.2±5.3)%;MSCs group: (70.8±4.6)%, (70.4±1-6.1)%; (33.8±3.4)%, (33.9±3.5)%; 5-aza-treated MSCs group: (71.7±6.8)%,(70.3±5.8)%; (34.7±5.7)%,(35.5±6.3)%; P< 0.05]. There was no significant difference in left ventricular end-diastolic dimension and end-systolic dimension between the cell transplantation group and control group. Myocardial contrast echocardiography (MCE) showed that the blood perfusion of the infarcted myocardium was obviously improved after the cells transplantation. (2) Dil-positive cells could be seen in all three bone marrow cells transplanted hearts group 8 weeks after cell transplantation, and Dil-positive cells expressed α-sarcomeric actin and desmin. The Dil positive cells appeared relative mature sarcomeric and sarcomere structure only in 5-aza-treated MSCs group. The capillary density in the cells transplantation group was much higher as compared with control group [(38.6±7.6)/mm2 (32.9±5.7)/mm2, (38.5±2.0)/mm2 (21.4±3.9)/mm2, P < 0.05]. There was no significant difference in each cell transplantation group. Conclusion: (1) Either the purified MSCs, 5-aza-treated MSCs or fresh separated bone marrow cells Gan survive in the infracted myocardium, expressing myocardium specific marks α-sarcomeric actin and desmin 8 weeks after transplantation. Left ventricle systolic function is improved markedly, capillary density is increased, and local blood perfusion is improved after transplantation. (2) 5-aza facilitate the maturation of MSCs into myocardial cells in vivo.

Cardiac Repair Effect of AKT Transfected Amniotic Fluid Mesenchymal Stem Cells on Ischemic Reperfusion ;injured Myocardium in Rabbits

The Transplantation of Akt-overexpressing Amniotic Fluid-Derived Mesenchymal Stem Cells Protects the Heart Against Ischemia-Reperfusion Injury in Rabbits

Effect of Genetically Modified Mesenchymal Stem Cells Derived from Amniotic Fluid on Oxidative Stress Levels in Myocardial Ischemia-Reperfusion Injury

Human Bone Marrow-Derived Mesenchymal Stem Cells Transplanted into Damaged Rabbit Heart to Improve Heart Function.

Allograftic Bone Marrow-Derived Mesenchymal Stem Cells Transplanted into Heart Infarcted Model of Rabbit to Renovate Infarcted Heart

Angiogenin Gene Transfer Improves Left Ventricular Function in Rats with Myocardial Infarction

SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction.

Effects of Mesenchymal Stem Cells Transplantation on Post-Infarction Ventricular Remodeling in Rats

Effects of bFGF-gene modified skeletal muscle satellite cell transplantation on cardiac function of acute myocardial infarction rabbits

Effect of autoplastic transplantation of rabbit bone marrow mononuclear cells on the restoration and rebuilding of ischemic myocardium and the amelioration of heart function

Optimal Temporal Delivery of Bone Marrow Mesenchymal Stem Cells in Rats with Myocardial Infarction.

In vitro purified and induced bone mesenchymal stem cells transplantation versus bone marrow mononuclear cells transplantation in treating myocardial infarction

Optimal Time for Mesenchymal Stem Cell Transplantation in Rats with Myocardial Infarction

MENSTRUAL BLOOD STEM CELLS IMPROVED MYOCARDIAL SURVIVAL AFTER RAT MYOCARDIAL INFARCTION BY PARACRINE

Experimental Study of Different Transplanting Ways of Derived Bone Marrow Mesenchymal Stem Cells in Treating Acute Myocardial Infarction

Improvement of Cardiac Function by Transplanting Autologous Mononuclear Bone Marrow Cells into Myocardial Infarction Scar and the Periphery

Comparative Investigation of Different Cells Transplantation on Cardiac Function of Rats with Ventricular Aneurysm after Myocardial Infarction

Myocardin-Related Transcription Factor-A-Overexpressing Bone Marrow Stem Cells Protect Cardiomyocytes And Alleviate Cardiac Damage In A Rat Model Of Acute Myocardial Infarction

Treatment of Rat Acute Myocardial Infarction with Transplantation of BMMSCs Induced by 5-Azacytidine

Image-guided Stem Cells with Functionalized Self-Assembling Peptide Nanofibers for Treatment of Acute Myocardial Infarction in a Mouse Model.

Adult Bone Marrow-Derived Mesenchymal Stem Cells Seeded on Tissue-Engineered Cardiac Patch Contribute to Myocardial Scar Remodeling and Enhance Revascularization in a Rabbit Model of Chronic Myocardial Infarction